Potentiation of the antimicrobial effect of Lactobacillus reuteri DSM 17938 cell-free extracts by ascorbic acid.

O. V. Knysh; A. V. Martynov

doi:10.26641/2307-0404.2020.1.200393

Автор(и)

O. V. Knysh https://orcid.org/0000-0002-4105-1299
A. V. Martynov https://orcid.org/0000-0003-1428-0085

DOI:

https://doi.org/10.26641/2307-0404.2020.1.200393

Ключові слова:

combinatorial (precursor-directed) biosynthesis, Lactobacillus reuteri DSM 17938 derivatives, modified ascorbic acid, HPLC-analysis

Анотація

The purpose of this study was to evaluate the effect of supplementing the culture medium with ascorbic acid on the antimicrobial properties of Lactobacillus reuteri cell-free extracts (CFEs). CFEs were prepared using commercial strain L. reuteri DSM 17938 by culturing lactobacilli in its own disintegrated cell suspension (DCS) supplemented with ascorbic acid in sub-inhibitory (5 mg/ml, CFE₅) or minimal inhibitory concentration (20 mg/ml, CFE₂₀) and without supplementation (CFE₀). Staphylococcus aureus AТСС 25923, Escherichia coli AТСС 25922 reference strains and Pseudomonas aeruginosa extensively drug resistant (XDR) clinical isolate were used as indicator cultures. Screening of the inhibitory properties of the studied CFEs and elucidation of the nature of inhibitory products were done using modified Micro scale Optical Density Assay (MODA). The inhibition indices (InhI) were calculated for the studied CFEs and ascorbic acid of appropriate concentrations. CFEs were subjected to HPLC-analysis. CFE₅ and CFE₂₀ showed significantly higher antimicrobial activity toward to indicator cultures than CFE₀. InhI calculated for extracts CFE₅ and CFE₂₀ mainly exceeded the sum of the corresponding indicators calculated for CFE₀ and ascorbic acid (АА) of appropriate concentrations: InhICFE₅ ≥ InhI CFE₀+ InhI AA₅; InhICFE₂₀ > InhI CFE₀+ InhI AA_20.Acidic metabolic products have made the greatest contribution to the antimicrobial effect of the studied CFEs. HPLC-nalysis showed that the modified ascorbic acid was the substance found in CFE₂₀ in the greatest quantity. The revealed effect of potentiation of antimicrobial activity of CFEs by ascorbic acid should be taken into account when developing new biotechnological products based on derivatives of L. reuteri DSM 17938.

Біографії авторів

O. V. Knysh

SI «I. I. Mechnikov Institute of Microbiology and Immunology of National Academy of Medical Sciences of Ukraine»
Pushkinska str., 14/16, Kharkiv, 61057, Ukraine

A. V. Martynov

SI «I. I. Mechnikov Institute of Microbiology and Immunology of National Academy of Medical Sciences of Ukraine»
Pushkinska str., 14/16, Kharkiv, 61057, Ukraine

Посилання

Czaplewski L, Bax R, Clokie M, Dawson M, Fairhead H, et al. Alternatives to antibiotics - a pipeline portfolio review. Lancet Infect Dis. 2016;16(2):239-51.

Greifová G, Májeková H, Greif G, Body P, Greifová M, Dubničková M. Analysis of antimicrobial and immunomodulatory substances produced by heterofermentative Lactobacillus reuteri. Folia Microbiol. 2017;62(6):515-24. doi: http://dx.doi.org/10.1007/s12223-017-0524-9

Stefania DM, Miranda P, Diana M, Claudia Z, Rita P, Donatella P. Antibiofilm and antiadhesive activities of different synbiotics. J Probiotics Health. 2017;5(3):1000182.

Navarro JB, Mashburn-Warren L, Bakaletz LO, Bailey MT, Goodman SD. Enhanced probiotic potential of Lactobacillus reuteri when delivered as a biofilm on dextranomer microspheres that contain beneficial cargo. Front Microbiol. 2017;8:489. doi: http://dx.doi.org/10.3389/fmicb.2017.00489

Etchebehere MC, Piveta C, Levy CE. The influence of glycerol upon L. reuteri activity against enteropathogens. Medical Express. 2017;4(6). doi: http://dx.doi.org/10.5935/medicalexpress.2017.06.06

Glantz SA. Primer of biostatistics. 7th ed. New York: McGraw-Hill; 2012. p. 327

Knysh OV, Isayenko OY, Voyda YV, Kizimenko OO, Babych YM. Influence of cell-free extracts of Bifidobacterium bifidum and Lactobacillus reuteri on proliferation and biofilm formation by Escherichia coli and Pseudomonas aeruginosa. Regul Mech Biosyst. 2019;10(2):251-6. doi: http://dx.doi.org/10.15421/021938

Lash BW, Gourama H, Mysliwiec TH. Microscale assay for screening of inhibitory activity of Lactobacillus. BioTechniques. 2002;33(6):1224-8. doi: http://dx.doi.org/10.2144/02336bm08

Mu Q, Tavella VJ, Luo XM. Role of Lactobacillus reuteri in human health and diseases. Front Microbiol. 2018;9:757. doi: http://dx.doi.org/10.3389/fmicb.2018.00757

Spinler JK, Auchtung J, Brown A, Boonma P, Oezguen N, Ross CL, et al. Next-generation probiotics targeting Clostridium difficile through precursor-directed antimicrobial biosynthesis. Infect Immun. 2017;85(10):e00303-17. doi: http://dx.doi.org/10.1128/iai.00303-17

Panda L. Antibacterial activity of ascorbic acid: pH effect, specific action or both? In abstracts of papers of the American chemical society (Vol. 255). 1155 16TH ST, NW, Washington, DC 20036. USA: Amer Chemical Soc; 2018. doi: http://dx.doi.org/10.13140/RG.2.2.22321.48482

Piqué N, Berlanga M, Miñana-Galbis D. Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview. Int J Mol Sci. 2019;20(10):2534. doi: http://dx.doi.org/10.3390/ijms20102534

Ang EL, Sun H, Liu Z, Zhao H. Recent advances in combinatorial biosynthesis for drug discovery. Drug Des Devel Ther. 2015;823. doi: http://dx.doi.org/10.2147/dddt.s63023

Singh A, Vishwakarma V, Singhal B. Metabiotics: The Functional Metabolic Signatures of Probiotics: Current State-of-Art and Future Research Priorities-Metabiotics: Probiotics Effector Molecules. Advances in Bioscience and Biotechnology. 2018;9(4):147-89. doi: http://dx.doi.org/10.4236/abb.2018.94012

Martynov AV, Bomko TV, Farber BS, Nosalskaya TN, Kleyn I. Synthesis of dynamic riboflavin derivatives and the study of their ability to urease photoinactivation. Annals of Mechnikov Institute. 2019;3:44-49. doi: http://doi.org/10.5281/zenodo.3469432.

Verghese RJ, Mathew SK, David A. Antimicrobial activity of Vitamin C demonstrated on uropathogenic Escherichia coli and Klebsiella pneumoniae. J Curr Res Sci Med. 2017;3:88-93 doi: http://dx.doi.org/10.4103/jcrsm.jcrsm_35_17